Jack Goldstein has joined Illumina's board of directors, the company said this week.
Goldstein most recently served as president and chief operating officer of Chiron until it was acquired by Novartis in April. Prior to Chiron, he spent two years as a general partner at Windamere Venture Partners, preceded by four years at Applied Imaging, first as president and CEO and then later as chairman.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
